Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Analysis of Immune Escape Variants from Antibody-Based Therapeutics against COVID-19: A Systematic Review
Daniele Focosi, Fabrizio Maggi, Massimo Franchini, et al.
International Journal of Molecular Sciences (2021) Vol. 23, Iss. 1, pp. 29-29
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Monoclonal antibody therapies against SARS-CoV-2
Daniele Focosi, Scott A. McConnell, Arturo Casadevall, et al.
The Lancet Infectious Diseases (2022) Vol. 22, Iss. 11, pp. e311-e326
Open Access | Times Cited: 205
Convergent Evolution in SARS-CoV-2 Spike Creates a Variant Soup from Which New COVID-19 Waves Emerge
Daniele Focosi, Rodrigo Quiroga, Scott A. McConnell, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2264-2264
Open Access | Times Cited: 117
Recombination in Coronaviruses, with a Focus on SARS-CoV-2
Daniele Focosi, Fabrizio Maggi
Viruses (2022) Vol. 14, Iss. 6, pp. 1239-1239
Open Access | Times Cited: 96
COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes
Daniele Focosi, Massimo Franchini, Liise-anne Pirofski, et al.
Clinical Microbiology Reviews (2022) Vol. 35, Iss. 3
Open Access | Times Cited: 89
Mucosal Vaccines, Sterilizing Immunity, and the Future of SARS-CoV-2 Virulence
Daniele Focosi, Fabrizio Maggi, Arturo Casadevall
Viruses (2022) Vol. 14, Iss. 2, pp. 187-187
Open Access | Times Cited: 87
Data-driven recombination detection in viral genomes
Tommaso Alfonsi, Anna Bernasconi, Matteo Chiara, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants
William R. Strohl, Zhiqiang Ku, Zhiqiang An, et al.
BioDrugs (2022) Vol. 36, Iss. 3, pp. 231-323
Open Access | Times Cited: 32
Outpatient treatment with concomitant vaccine-boosted convalescent plasma for patients with immunosuppression and COVID-19
Juan G. Ripoll, Sidna M. Tulledge‐Scheitel, Anthony A. Stephenson, et al.
mBio (2024) Vol. 15, Iss. 5
Open Access | Times Cited: 6
Potent universal beta-coronavirus therapeutic activity mediated by direct respiratory administration of a Spike S2 domain-specific human neutralizing monoclonal antibody
Michael S. Piepenbrink, Jun‐Gyu Park, Ashlesha Deshpande, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 7, pp. e1010691-e1010691
Open Access | Times Cited: 26
Clinical Management of Patients With B-Cell Depletion Agents to Treat or Prevent Prolonged and Severe SARS-COV-2 Infection: Defining a Treatment Pathway
Alessandra D’Abramo, Serena Vita, Gaetano Maffongelli, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 23
Spike-protein proteolytic antibodies in COVID-19 convalescent plasma contribute to SARS-CoV-2 neutralization
Scott A. McConnell, Jaiprasath Sachithanandham, Nathan J. Mudrak, et al.
Cell chemical biology (2023) Vol. 30, Iss. 7, pp. 726-738.e4
Open Access | Times Cited: 12
Prescription of Anti-Spike Monoclonal Antibodies in COVID-19 Patients with Resistant SARS-CoV-2 Variants in Italy
Daniele Focosi, Marco Tuccori
Pathogens (2022) Vol. 11, Iss. 8, pp. 823-823
Open Access | Times Cited: 21
SARS‐CoV‐2 intrahost evolution in immunocompromised patients in comparison with immunocompetent populations after treatment
Akram Sadat Ahmadi, Sevrin Zadheidar, Kaveh Sadeghi, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 6
Closed Access | Times Cited: 11
A Web Tool to Estimate Baseline Anti-Spike Monoclonal Antibody Efficacy Based on Regional Genomic Surveillance
Daniele Focosi
Viruses (2023) Vol. 15, Iss. 5, pp. 1048-1048
Open Access | Times Cited: 9
Data-driven recombination detection in viral genomes
Tommaso Alfonsi, Anna Bernasconi, Matteo Chiara, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 9
Spike and nucleocapsid antibody dynamics following SARS‐CoV‐2 infection and vaccination: Implications for sourcing COVID‐19 convalescent plasma from routinely collected blood donations
Clara Di Germanio, Xutao Deng, Brendan G. Balasko, et al.
Transfusion (2024) Vol. 64, Iss. 11, pp. 2063-2074
Open Access | Times Cited: 2
Antibody response and intra‐host viral evolution after plasma therapy in COVID‐19 patients pre‐exposed or not to B‐cell‐depleting agents
David Gachoud, Trestan Pillonel, Γεράσιμος Τσιλιμιδός, et al.
British Journal of Haematology (2022) Vol. 199, Iss. 4, pp. 549-559
Open Access | Times Cited: 11
Rapid Manufacturing of Highly Cytotoxic Clinical-Grade SARS-CoV-2-specific T Cell Products Covering SARS-CoV-2 and Its Variants for Adoptive T Cell Therapy
Agnes Bonifacius, Sabine Tischer‐Zimmermann, Maria Michela Santamorena, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 10
Variant-specific humoral immune response to SARS-CoV-2 escape mutants arising in clinically severe, prolonged infection
Theresa Günther, Michael Schöfbänker, Eva U. Lorentzen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Monoclonal Antibody Therapies Against SARS-CoV-2: Promises and Realities
Daniele Focosi
Current topics in microbiology and immunology (2024)
Closed Access | Times Cited: 1
Sotrovimab-emergent resistance in SARS-CoV-2 Omicron: A series of three cases
Daniele Focosi, Federica Novazzi, Andreina Baj, et al.
Journal of Clinical Virology Plus (2022) Vol. 2, Iss. 3, pp. 100097-100097
Open Access | Times Cited: 8
Identifying Markers of Emerging SARS-CoV-2 Variants in Patients With Secondary Immunodeficiency
Nathan M. Markarian, Gaël Galli, Dhanesh Patel, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 8
PG-Triggers: Triggers for Property Graphs
Stefano Ceri, Anna Bernasconi, Alessia Gagliardi, et al.
(2024), pp. 373-385
Open Access | Times Cited: 1
Efficacy of convalescent plasma in hospitalized COVID-19 patients: findings from a controlled trial
Tânia Portella Costa, Mateus Nóbrega Aoki, Camilla Moreira Ribeiro, et al.
Brazilian Journal of Medical and Biological Research (2024) Vol. 57
Open Access | Times Cited: 1
Analysis of the Neutralizing Activity of Antibodies Targeting Open or Closed SARS-CoV-2 Spike Protein Conformations
Gabriel Cia, Fabrizio Pucci, Marianne Rooman
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 4, pp. 2078-2078
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top